Analyst Price Target is $9.00
▲ +56.25% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Harvard Bioscience in the last 3 months. The average price target is $9.00, with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 56.25% upside from the last price of $5.76.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Harvard Bioscience. This rating changed within the last month from a Buy consensus rating.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.